Cosmo pharmaceuticals and medtronic forge ahead in ai-driven care

Agreement expands partnership between cosmo pharmaceuticals and medtronic, set to transform endoscopy with cutting-edge ai technology ad hoc announcement pursuant to art. 53 lr dublin, ireland--(newsfile corp. - december 11, 2023) - cosmo pharmaceuticals (six: copn) (xetra: c43) (“cosmo”) announces that its subsidiary cosmo intelligent medical devices has entered into a definitive agreement to expand its partnership with medtronic plc (nyse: mdt), a global leader in healthcare technology.
MDT Ratings Summary
MDT Quant Ranking